Platelet Survival
Mostrando 1-12 de 108 artigos, teses e dissertações.
-
1. Blood count and fasting blood glucose level in the assessment of prognosis and survival in advanced cervical cancer
SUMMARY OBJECTIVE: The objective of this study was to verify whether the parameters of the blood count and the fasting glucose level before treatment are related to prognosis and survival in cervical cancer (IIB–IVB staging). METHODS: Patients with cervical cancer (stages IIB–IVB) were evaluated (n=80). Age, parity, staging, histological grade, histolo
Revista da Associação Médica Brasileira. Publicado em: 2022
-
2. A Retrospective Study of the Relationship Between Blood Transfusion and 30-Day Postoperative Outcomes in Patients Undergoing Isolated Off-Pump Coronary Artery Bypass Grafting
ABSTRACT Introduction: The objective of this single-center study it to retrospectively analyze the relationship between transfusion and 30-day postoperative outcomes in patients undergoing isolated off-pump coronary artery bypass grafting. Methods: Perioperative data of 2,178 patients who underwent isolated off-pump coronary artery bypass grafting from 201
Brazilian Journal of Cardiovascular Surgery. Publicado em: 2022
-
3. Hematological changes in SARS-COV-2 positive patients
Abstract Introduction The novel SARS-CoV-2 infection has been spreading around the world since January 2020 causing the Corona Virus Disease 2019. Leukopenia, lymphopenia and hypercoagulability with elevated D- Dimers have been described in COVID-19 patients to date. This study aimed to clarify if some blood parameters can be used as biomarkers to facilitat
Hematology, Transfusion and Cell Therapy. Publicado em: 2022
-
4. Overall survival prediction in metastatic castration-resistant prostate cancer treated with radium-223
ABSTRACT Objective Radium-223(223Ra) is indicated for patients (p) with metastatic castration resistant prostate cancer (mCRCP). Objectives The aim of this study was to evaluate the role of baseline clinical variables associated with overall survival (OS) and toxicity of 223Ra. Its purpose was to identify the factors that can predict a better response to
Int. braz j urol.. Publicado em: 2020-08
-
5. Haploidentical transplantation outcomes are comparable with those obtained with identical human leukocyte antigen allogeneic transplantation in Chilean patients with benign and malignant hemopathies
Abstract Introduction Patients with benign or malignant blood disorders, who require allogeneic stem cell transplantation and lack an identical human leukocyte antigen HLA identicalHL sibling donor, could be transplanted with hematopoietic stem cells from unrelated adult or umbilical cord donors. However, in our country, both approaches are costly and time-
Hematol., Transfus. Cell Ther.. Publicado em: 2020-03
-
6. Spontaneous splenic rupture associated with multiple myeloma: a serious and unusual case
Abstract Introduction Patients with benign or malignant blood disorders, who require allogeneic stem cell transplantation and lack an identical human leukocyte antigen HLA identicalHL sibling donor, could be transplanted with hematopoietic stem cells from unrelated adult or umbilical cord donors. However, in our country, both approaches are costly and time-
Hematol., Transfus. Cell Ther.. Publicado em: 2020-03
-
7. Comparison of the prognostic value of platelet-based prognostic models in patients with malignant hepatic tumors after TACE therapy
Abstract Purpose: To investigate the prognostic value of 17 platelet-based prognostic scores in patients with malignant hepatic tumors after TACE therapy. Methods: In total, 92 patients were divided into death group and survival group according to long-term follow-up results. The AUC was calculated to determine the optimal cut-off values for predicting pro
Acta Cir. Bras.. Publicado em: 16/09/2019
-
8. Does BCR-ABL transcript type influence the prognosis of patients in chronic myelogenous leukemia chronic phase?
ABSTRACT Introduction and objective: In this study, we evaluated the influence of the transcript type on hematological and clinical parameters, as well as the event-free survival of 50 patients in the Chronic myeloid leukemia chronic phase. Methods: We reviewed the medical records of 55 patients with Chronic myeloid leukemia. The eligibility criteria were
Hematol., Transfus. Cell Ther.. Publicado em: 10/06/2019
-
9. Assessing the impact of ABO incompatibility on major allogeneic hematopoietic stem cell transplant outcomes: a prospective, single-center, cohort study
Abstract Background ABO blood group incompatibility between donor and recipient is associated with a number of immunohematological complications, but is not considered a major contraindication to allogeneic hematopoietic stem cell transplantation. However, available evidence from the literature seems to be conflicting as to the impact of incompatibility on
Hematol., Transfus. Cell Ther.. Publicado em: 15/04/2019
-
10. Platelet activating factor receptor antagonists improve the efficacy of experimental chemo- and radiotherapy
Platelet activating factor is a lipid mediator of inflammation, and in recent decades, it has emerged as an important factor in tumor outcomes. Platelet activating factor acts by specific binding to its receptor, which is present in both tumor cells and cells that infiltrate tumors. Pro-tumorigenic effects of platelet activating factor receptor in tumors inc
Clinics. Publicado em: 11/10/2018
-
11. Nutritional assessment as predictor of complications after hematopoietic stem cell transplantation
ABSTRACT Introduction: Nutritional support is pivotal in patients submitted to hematopoietic stem cell transplantation. Nutritional status has been associated with time of engraftment and infection rates. In order to evaluate the association between nutritional parameters and clinical outcomes after transplantation a cohort of transplant patients was retros
Rev. Bras. Hematol. Hemoter.. Publicado em: 2016-02
-
12. Unrelated hematopoietic stem cell transplantation in the pediatric population: single institution experience
OBJECTIVE: Hematopoietic stem cell transplantation has been successfully used to treat the pediatric population with malignant and non-malignant hematological diseases. This paper reports the results up to 180 days after the procedure of all unrelated hematopoietic stem cell transplantations in pediatric patients that were performed in one institution.METHOD
Rev. Bras. Hematol. Hemoter.. Publicado em: 2015-08